Trials / Completed
CompletedNCT03351556
Optimizing the Efficiency and Implementation of Cash Transfers to Improve Adherence to Antiretroviral Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 530 (actual)
- Sponsor
- University of California, Berkeley · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
1. Determine the "dose-response" relationship between a cash transfer amount and HIV viral suppression at 6 months 2. Identify the most effective cash transfer size to increase the proportion of people living with HIV infection (PLHIV) retained in care and with suppressed viral load (\<1000 copies/ml) after 6 months. (This amount will be further evaluated in a cluster randomized trial in Phase 2).
Detailed description
Participants in the control group will receive the standard HIV primary care services according to Tanzania's National Guidelines for the Management of HIV and AIDS. The study has two active intervention arms: 1. The opportunity to earn 10,000 TZS/month (\~$4.50) for up to 6 months conditional on visit attendance, and 2. The opportunity to earn 22,500 TZS/month (\~$10.00) for up to 6 months conditional on visit attendance In both intervention arms, cash transfers will be delivered a maximum of once monthly, spaced ≥28 days apart, for up to six months and delivered via an automatic mobile money system linked to a biometric identification system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Active Arm 1 | Participants in this arm will receive the standard HIV primary care services according to Tanzania's National Guidelines for the Management of HIV and AIDS plus the opportunity to earn 10,000 TZS/month conditional on visit attendance. |
| BEHAVIORAL | Active Arm 2 | Participants in this arm will receive the standard HIV primary care services according to Tanzania's National Guidelines for the Management of HIV and AIDS plus the opportunity to earn 22,500 TZS/month conditional on visit attendance. |
Timeline
- Start date
- 2018-04-24
- Primary completion
- 2019-06-30
- Completion
- 2019-06-30
- First posted
- 2017-11-24
- Last updated
- 2022-08-22
Locations
4 sites across 1 country: Tanzania
Source: ClinicalTrials.gov record NCT03351556. Inclusion in this directory is not an endorsement.